Industry Sponsored Clinical Trials Indirect Cost Rates

The industry sponsored clinical trials indirect rate is set by the Office of Research and Innovation in coordination with the College of Medicine and Research Accounting Services. This rate is to be applied for all industry sponsored clinical trials/research. Federally sponsored clinical trials must use the federally negotiated indirect cost rate.  The current and historical rates are listed below:

 

 

Effective

April 1, 2021

Prior to

April 1, 2021

Industry Sponsored Clinical Trials Indirect Cost Rate
 35%  30%

For questions concerning the use of the industry sponsored clinical trials indirect cost rate, please contact ras@drexel.edu.